Scarica l'app Stockscreener
3.465
1.61%
0.045
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reportsJuly 2025 Highlights & Community Supported Trade Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Rocket Pharmaceuticals Inc. Equity Warrant stock bottoming outQuarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Will Rocket Pharmaceuticals Inc. stock go up soonJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Should you hold or exit Rocket Pharmaceuticals Inc. now2025 Trading Volume Trends & Real-Time Buy Signal Notifications - newser.com
Published on: 2025-10-10 06:17:17 - newser.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Published on: 2025-10-10 04:39:16 - newser.com
Building trade automation scripts for Rocket Pharmaceuticals Inc. Equity Warrant2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc. Equity WarrantMarket Volume Report & High Win Rate Trade Alerts - newser.com
How sentiment analysis helps forecast Rocket Pharmaceuticals Inc. Equity WarrantPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock profit from fiscal stimulusEarnings Beat & Intraday High Probability Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Reach Out - ACCESS Newswire
How to manage a losing position in Rocket Pharmaceuticals Inc. Equity Warrant2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 05:44:17 - newser.com
Published on: 2025-10-09 03:18:17 - newser.com
Can a trend reversal in Rocket Pharmaceuticals Inc. Equity Warrant lead to recovery2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
Automated trading signals detected on Rocket Pharmaceuticals Inc. Equity WarrantWeekly Market Report & Safe Entry Point Identification - newser.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Pass Below 50-Day Moving AverageWhat's Next? - MarketBeat
What drives Rocket Pharmaceuticals Inc stock priceBollinger Bands Signals & Free Dynamic Capital Growth - earlytimes.in
Rocket Pharmaceuticals Pulls BLA for Fanconi Anemia Gene Therapy RP-L102 - CGTLive®
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to global recession fearsJuly 2025 Trends & Risk Controlled Daily Trade Plans - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock ready for a breakout2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
Rocket Pharmaceuticals Inc. Equity Warrant stock volume spike explainedPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Using AI based signals to follow Rocket Pharmaceuticals Inc. Equity WarrantMarket Performance Summary & Weekly High Conviction Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Combining price and volume data for Rocket Pharmaceuticals Inc. Equity WarrantEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Real time social sentiment graph for Rocket Pharmaceuticals Inc. Equity WarrantTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock positioned well for digital economyGap Up & Community Verified Trade Signals - newser.com
Understanding Rocket Pharmaceuticals Inc. Equity Warrant’s price movementJuly 2025 PreEarnings & Accurate Intraday Trade Tips - newser.com
Is now a turning point for Rocket Pharmaceuticals Inc.2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-10-05 06:51:42 - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock resilient to inflationMarket Activity Report & Real-Time Volume Spike Alerts - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock a buy for dividend portfolios2025 Retail Activity & Safe Entry Zone Identification - newser.com
Comparing Rocket Pharmaceuticals Inc. Equity Warrant in custom built stock radarsJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Rocket Pharmaceuticals board member Pedro Granadillo resigns - StreetInsider
Leerink Partners Maintains Rocket Pharmaceuticals (RCKT) Market Perform Recommendation - Nasdaq
Rocket Pharmaceuticals announces board resignation of Pedro Granadillo - Investing.com
Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy - MedCity News
Rocket Pharmaceuticals (RCKT) Withdraws U.S. Filing for Gene The - GuruFocus
Leerink Partners Adjusts Rocket Pharmaceuticals Price Target to $7 From $9, Maintains Market Perform Rating - MarketScreener
Rocket Pharma pulls BLA for gene therapy RP-L102 in the USA - The Pharma Letter
Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy - Stocktwits
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Cut to $7.00 by Analysts at Leerink Partners - MarketBeat
RCKT: Analyst Lowers Price Target for Rocket Pharmaceuticals | R - GuruFocus
Leerink Partners Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating, Announces Target Price $7 - 富途牛牛
Rocket Pharmaceuticals (RCKT) Halts U.S. Application for Gene Th - GuruFocus
Using R and stats models for Rocket Pharmaceuticals Inc. Equity Warrant forecasting2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Rocket Pharmaceuticals withdraws US application for blood disorder gene therapy - MarketScreener
Rocket Pharmaceuticals withdraws BLA for gene therapy RP-L102 in the US - Investing.com
Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder - Yahoo
Rocket Pharmaceuticals withdraws gene therapy application from FDA - StreetInsider
Will Rocket Pharmaceuticals Inc. rebound enough to break evenSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock outperform small cap peers2025 Buyback Activity & Target Return Focused Picks - newser.com
3.07%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):